TLR2 expression was associated with COVID-19 severity, being identified as a sensor of SARS-CoV-2 that drives inflammatory cytokine production, potentially contributing to the dysregulated immune response observed in patients with severe COVID-19 [119]. This evidence concerns the gene TLR2 and COVID-19.